{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.1","upperLimit":"4.5","value":"1.8"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"38"}],"units":"MNC collections"}],"description":"The hematocrit of the collected product was used to quantitate Red Blood Cell (RBC) contamination.","dispersionType":"Full Range","groups":[{"description":"Multiple myeloma patients infused with autologous peripheral blood stem cells collected on the Spectra Optia Apheresis System.","id":"OG000","title":"All Per Protocol Patients"}],"paramType":"MEDIAN","populationDescription":"Data was available from 38 MNC collections from 25 of the 26 per protocol patients.","reportingStatus":"POSTED","timeFrame":"7 days","title":"Hematocrit of MNC Product","type":"SECONDARY","typeUnitsAnalyzed":"MNC collections","unitOfMeasure":"hematocrit %"}